QOL-07 DESCRIPTION OF CLINICAL AND PATIENT REPORTED OUTCOMES ASSESSMENTS FROM A PHASE 3, MULTICENTER, RANDOMIZED TRIAL EVALUATING NIVOLUMAB MONOTHERAPY VERSUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA: CHECKMATE-143

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Nayak, Lakshmi, Brandes, Alba, Omuro, Antonio, Rieger, Johannes, Wick, Antje, Phuphanich, Surasak, Sumrall, Ashley, Sahebjam, Solmaz, Ahluwalia, Manmeet, de Souza, Paul, Sepulveda, Juan Manuel, Maio, Michele, Grauer, Oliver, Vlahovic, Gordana, Baehring, Joachim, Dastani, Homa, Latek, Robert, Coric, Vlad, Reardon, David
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2015
Предметы:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov230.07
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы